Envestnet Asset Management Inc Lexicon Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$1.44 - $2.1 $120,106 - $175,154	-83,407 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$1.75 - $2.3 $145,962 - $191,836	83,407 New	83,407 $166,000
Q4 2017 Feb 20, 2018	SELL	$8.77 - $12.28 $18,539 - $25,959	-2,114 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.17 - $16.3 $1,338 - $1,793	110 Added 5.49%	2,114 $26,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,004	2,004 $32,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.